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A BRlEF COMMUNICATION 
EOSINOPHILS AND THE LUNG IN TROPICAL
PULMONARY EOSINOPHILIA
Tropical pulmonary eosinophilia (TPE) is commonly
seen in areas endemic for filariasis. It must be
remembered that the respiratory manifestations are
part of a systemic disease characterised by marked
increase in the blood eosinophil counts, malaise,
fever and weight loss in addition to the respiratory
symptoms. The clinical and laboratory features of
the disorder have been extensively reviewed.1-4
The disorder has been known for over 50 years
now, but the association with filarial disease began to
be recognised with the demonstration of antifilarial
antibodies and the findings of microfilariae in the
tissue. Also of interest is the occurrence of high
levels of IgE in the sera of these patients. Both
animal and human filarial parasites have figured as
etiological agents of the syndrome. Currently it is
believed to represent an abnormal response to human
parasite rather than sensitization to animal parasites5.
The most significant haematological abnormality in
this disorder is the intense eosinophilia which is an
integral part of the syndrome. Before we consider the
 role of eosinophils in this disorder, a brief review of
our current state of knowledge of these cells is in
order. The immunobiology of the eosinophils6 and
eosinophilia7 have recently been well reviewed.
The eosinophil was first described by Ehrlich over
a hundred years ago. The cell is easily recognised
by the characteristic granules that it possesses. The
structure and content of these granules have been
extensively studied during the last decade. There
are at least two types of granules within the eosinophil.
The large granules contain an electron dense core
and a matrix. Four major proteins with diverse bio-
logical functions have been identified within the
large granule. The most abundant of these which
forms the crystalloid core is the major basic protein
(MBP). MBP has been shown to be toxic to several
parasites. Like other granulocytes, eosinophils also
have a peroxidase which is capable of killing microbes
by virtue of its ability to generate oxidants. Eosino-
phil cationic proteins (ECP) have profound effects on
the coagulation system besides being toxic to para-
sites. The fourth protein is the eosinophil derived
neutrotoxin which can produce extensive damage in
experimental animals referred to as the “Gordon
phenomenon”.
The small granules contain a variety of enzymes
such as aryl sulfatase and collagenases. The plasma
membrane of the eosinophil contains lysophospholi-
pase which crystallises to form the familiar Charcot-
Leyden crystals.
Several abnormalities of the eosinophils have been
identified in TPE. These include appearance of
cytoplasmic vacuoles8 and degranulation.9 It must
be noted that there is no relationship between the
eosinophil counts and the clinical or radiological
features of this disorder.
It has now been clearly established that eosinophils
play an important part in immune mediated injury to
parasites. However, of interest is the growing
body of information that these cells may be injurious
to tissues, particularly the lung. Their role in the
various allergic reactions was hitherto believed to be
one of controlling the immediate hypersensitivity
reactions. This view was based on the observation
that the eosinophil possessed enzymes that could
neutralise mediator activity. Recently Gleich et al6
have convincingly shown that the eosinophil is an
effector cell in immediate hypersensitivity reactions
and may be responsible for a significant portion of the
damage caused by such reactions. Extensive damage
to the architecture of the bronchi with pathological
changes similar to bronchial asthma have been traced
to MBP activity. Eosinophils have been shown to
be capable of releasing leukotrienes which are potent
bronchospastic agents. Moreover, Davis et al10
have demonstrated the presence of collagenases which
are capable of cleaving lung collagen which could
play an important role in the cytotoxicity of eosino-
philia to normal tissue.
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Weller and Goetz 11 recognised the lung as the
prime target organ of eosinophil injury. The findings
of Cantin et al12 that the lung has poor anti-oxidant
potential suggest that this may be one of the factors
which renders the lung susceptible to eosinophil
mediated injury.
The relationship of eosinophils to lung injury in
TPE has not been well established. It is not clearly
known what stimuli attract eosinophils to the lung
in TPE. Also unexplored is the possibility that
eosinophils are responsible for the bronchospasm seen
in this disorder either directly by their ability to release
leukotrienes or by their capacity to activate basophils
or mast cells. Such questions await examination of
the issue by adopting techniques which can further
probe into the functions of eosinophils within the
lung.
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